A randomized controlled trial for Traditional Chinese Medicine in the treatment for Novel Coronavirus Pneumonia (COVID-19)

INTERVENTION: experimental group :Traditional Chinese medicine compound granules + western medicine symptomatic treatment ;control group:western medicine symptomatic treatment ; CONDITION: Novel Coronavirus Pneumonia (COVID‐19) PRIMARY OUTCOME: Number of worsening events; SECONDARY OUTCOME: Total duration of disease;Average length of hospital stay;Time needed for healing;Negative rate of respiratory virus nucleic acid;Time from treatment to the beginning of antipyretic;Time from treatment to complete antipyretic;Chest imaging;Incidence of adverse events; INCLUSION CRITERIA: 1. Meet the diagnostic criteria for suspected and confirmed cases (including mild, general, and severe) in the Diagnosis and Treatment of Pneumonia of New Coronavirus Pneumonia (Trial Version 5); 2. Meet the TCM diagnostic criteria for each stage of the novel coronavirus pneumonia; 3. Aged 18‐75 years‐old men or women; 4. Patients who volunteer to participate in this study and sign informed consent.